Apart from its physiological role as a counter-regulator of GC effects, elevated MIF expression seems to play a major role in several autoimmune disorders, including rheumatoid arthritis and autoimmune hepatitis [12,17,18], and renders anti-MIF treatment [41,42] a promising therapeutic strategy. This evidence concerns the gene MIF and autoimmune disease.